USD 0.13
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 165.03 Million | 149.51 Million | 434.95 Million | 180.29 Million | 216.25 Million | 88.12 Million |
Net Income | -6.65 Million | -20.22 Million | 512.92 Thousand | 46.55 Million | 55.05 Million | 51.6 Million |
Depreciation & Amortization | 189.61 Million | 186.38 Million | 166.69 Million | 157.85 Million | 154.9 Million | 98.09 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -10.11 Million | -3.07 Million | 276.33 Million | -15.73 Million | 9.75 Million | -51.34 Million |
Other non-cash items | -7.8 Million | -13.56 Million | -8.59 Million | -8.38 Million | -3.46 Million | 238.33 Million |
Investing Cash Flow | -218.29 Million | 162.31 Million | -707.31 Million | -109.62 Million | -157.34 Million | -74.59 Million |
Investments in PPE | -61.58 Million | -81.15 Million | -373.66 Million | -102.52 Million | -90.6 Million | -65.52 Million |
Acquisitions | - | - | - | - | -60.31 Million | 127.72 Thousand |
Investment purchases | -389.08 Million | -5.88 Million | -333.65 Million | -7.09 Million | -6.41 Million | -9.19 Million |
Sales/Maturities of investments | 232.37 Million | 249.36 Million | - | - | - | - |
Other Investing Activities | -136 Million | - | -593.33 Million | -20.12 Million | -1.00 | 13.02 Million |
Financing Cash Flow | -97.43 Million | -97.67 Million | -219.65 Million | -91.95 Million | -590.1 Million | -545.12 Million |
Debt repayment | -51.22 Million | -51.5 Million | -51.04 Million | -54.43 Million | -57.49 Million | -498.12 Million |
Dividends payments | -46.21 Million | -46.21 Million | -168.62 Million | -37.52 Million | -532.61 Million | -47 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -51.21 Million | -51.46 Million | -51.03 Million | -54.42 Million | -57.49 Million | -1.00 |
Accounts receivables | -6.4 Million | -6.27 Million | 17.43 Million | -43.72 Million | 2.31 Million | -9.45 Million |
Accounts payables | -3.45 Million | 1.66 Million | 257.99 Million | 34.56 Million | 128.34 Thousand | -45.21 Million |
Inventory | -384.09 Thousand | -512.04 Thousand | -512.92 Thousand | -7.35 Million | 6.67 Million | 2.29 Million |
Other working capital | 128.03 Thousand | 2.04 Million | 1.41 Million | 773.8 Thousand | 641.7 Thousand | 1.02 Million |
Cash at beginning of period | 395.16 Million | 181.31 Million | 677.21 Million | 695.08 Million | 1.22 Billion | 1.75 Billion |
Cash at end of period | 244.53 Million | 395.16 Million | 181.31 Million | 677.21 Million | 695.08 Million | 1.22 Billion |
Capital Expenditure | -61.58 Million | -81.15 Million | -373.66 Million | -102.52 Million | -90.6 Million | -65.52 Million |
Effect of forex changes on cash | 61.74 Thousand | -311.08 Thousand | -3.87 Million | -0.35 | -0.11 | - |
Net cash flow / Change in cash | -150.62 Million | 213.84 Million | -495.89 Million | -17.87 Million | -525.31 Million | -534.29 Million |
Free Cash Flow | 103.44 Million | 68.35 Million | 61.29 Million | 77.76 Million | 125.64 Million | 22.6 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -768.34 Thousand | -766.72 Thousand | -4.22 Million | -6.65 Million | -2.1 Million | -2.42 Million |
Depreciation & Amortization | 47.18 Million | 47.08 Million | 94.99 Million | 189.61 Million | 35.5 Million | 94.27 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 64.02 Thousand | 63.89 Thousand | -11.77 Million | -10.11 Million | -4.15 Million | 1.65 Million |
Other non-cash items | -12.61 Million | -12.58 Million | 202.03 Million | -7.8 Million | 3.57 Million | 178.98 Million |
Investing Cash Flow | -73.37 Million | -73.22 Million | 100.24 Million | -218.29 Million | 56.69 Million | -317.39 Million |
Investments in PPE | -10.62 Million | -10.6 Million | -40.71 Million | -61.58 Million | -20.3 Million | -20.79 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -292.8 Million | - | -91.41 Million | -389.08 Million | - | -296.6 Million |
Sales/Maturities of investments | 157.47 Million | - | 232.37 Million | 232.37 Million | - | - |
Other Investing Activities | -62.74 Million | -62.61 Million | 77.22 Million | -136 Million | 77 Million | -144.71 Million |
Financing Cash Flow | -28.74 Million | -28.68 Million | -39.17 Million | -97.43 Million | -19.53 Million | -58.04 Million |
Debt repayment | - | - | - | -51.22 Million | - | - |
Dividends payments | -16.07 Million | -16.03 Million | -14.08 Million | -46.21 Million | -7.02 Million | -32.02 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -12.67 Million | -12.65 Million | -12.55 Million | -51.21 Million | -12.51 Million | -13.01 Million |
Accounts receivables | -1.92 Million | -1.91 Million | -3.96 Million | -6.4 Million | -1.97 Million | -2.42 Million |
Accounts payables | -11.65 Million | - | -3.45 Million | -3.45 Million | - | - |
Inventory | 1.98 Million | 1.98 Million | -4.35 Million | -384.09 Thousand | -2.17 Million | 3.95 Million |
Other working capital | - | - | - | 128.03 Thousand | - | 127.56 Thousand |
Cash at beginning of period | 244.53 Million | - | 103.84 Million | 395.16 Million | - | 395.16 Million |
Cash at end of period | 108.05 Million | -68.11 Million | 244.53 Million | 244.53 Million | 69.98 Million | 103.84 Million |
Capital Expenditure | -10.62 Million | -10.6 Million | -40.71 Million | -61.58 Million | -20.3 Million | -20.79 Million |
Effect of forex changes on cash | - | - | 374.44 Thousand | 61.74 Thousand | - | -1.00 |
Net cash flow / Change in cash | -136.47 Million | -68.11 Million | 140.69 Million | -150.62 Million | 69.98 Million | -291.32 Million |
Free Cash Flow | 23.24 Million | 23.19 Million | 38.53 Million | 103.44 Million | 12.51 Million | 64.67 Million |
FFI
URAL
CLGPF
EASEMYTRIP
SVCBF
CRP